Planning Application: 236059 (Cork County Council )
File Number:
236059
Application Type:
PERMISSION
Planning Status:
APPLICATION FINALISED
Received Date:
11/10/2023
Decision Due Date:
05/12/2023
Validated Date:
23/10/2023
Invalidated Date:
Further Info Requested:
Further Info Received:
Withdrawn Date:
Extend Date:
Decision Type:
Conditional
Decision Date:
04/12/2023
Leave to Appeal:
Appeal Date:
Commenced Date:
Submissions By:
14/11/2023
Applicant Details
Applicant name:
Eli Lilly Kinsale Limited
Applicant Address:
Phone Number:
Fax Number:
Corresp.
Address:
Applicant Details
Proposed Development
Development Description:
The development will consist of: a) a 3 storey administration extension (gross floor area approx. 523sq.m and approx. 26m high to parapet) with intermediate mezzanine floors for welfare, office and storage use to the existing IE2b pharmaceutical manufacturing building with roof mounted plant and equipment, all located to the north east of the existing IE2b building; b) a single storey extension to the ground floor of the existing nanofiltration room located on the eastern side of the IE2b production building (gross floor area 8sq.m); c) local ancillary site development works including modifications to underground services and hard surfaced areas. The proposed development is covered by an existing industrial emissions (IE) licence no. P0009-05. The development refers to a modification to an establishment to which the major accident regulations applies.
Development Address:
The Existing Eli Lilly Pharmacuetical complex at, Ballythomas East, Ballythomas West, , Horse Hill More North and Ballyvrin Lower,, Dunderrow, Kinsale, Co.Cork
Architect Name:
Location Key:
BALLYTHOMAS WEST
Electoral Division:
Planner:
Social Housing Exempt:
Plan Enforcement #:
IPC
Licence Required:
Waste Licence Required:
Protected Structure:
Protected Structure #:
Development Name:
Proposed Development
Comments
Significant Case Flag:
No
Comments:
Decision
Decision Date:
04/12/2023
Manager Order:
5827
Decision Type:
Conditional
Number of Conditions:
2
Grant Date:
19/01/2024
Grant Managers Order #:
Section 47
Apply?:
Part 5
Apply?:
No
Expiry Date:
Decision Description:
The development will consist of: a) a 3 storey administration extension (gross floor area approx. 523sq.m and approx. 26m high to parapet) with intermediate mezzanine floors for welfare, office and storage use to the existing IE2b pharmaceutical manufacturing building with roof mounted plant and equipment, all located to the north east of the existing IE2b building; b) a single storey extension to the ground floor of the existing nanofiltration room located on the eastern side of the IE2b production building (gross floor area 8sq.m); c) local ancillary site development works including modifications to underground services and hard surfaced areas. The proposed development is covered by an existing industrial emissions (IE) licence no. P0009-05. The development refers to a modification to an establishment to which the major accident regulations applies.
